Aspergilosis pulmonar invasiva en paciente pediátrico

The growing emergence of infectious diseases and increasing the number of individuals that have affected their immune competence has become a challenge. Furthermore, considering the genus Aspergillus, as an etiologic agent of infection, which causes significant morbidity and mortality in immunocompr...

Full description

Bibliographic Details
Main Authors: Jenny Planchet, Rosanny García, Zuneth González, Aura Mendoza
Format: Article
Language:English
Published: Universidad Central de Venezuela, Facultad de Medicina. 2021-08-01
Series:Revista Digital de Postgrado
Subjects:
Online Access:http://saber.ucv.ve/ojs/index.php/rev_dp/article/view/22820
_version_ 1797428480682491904
author Jenny Planchet
Rosanny García
Zuneth González
Aura Mendoza
author_facet Jenny Planchet
Rosanny García
Zuneth González
Aura Mendoza
author_sort Jenny Planchet
collection DOAJ
description The growing emergence of infectious diseases and increasing the number of individuals that have affected their immune competence has become a challenge. Furthermore, considering the genus Aspergillus, as an etiologic agent of infection, which causes significant morbidity and mortality in immunocompromised patients. We present a case of a female preschool 3 years and 8 months with a history of mature teratoma fetiforme, who after 6 months of excision, computed tomography (CT) scan control is performed where central bronchiectasis are evident with tubular opacities and saculares bronchial distribution, located mainly in the upper lobe of left chest, decreased left lung volume with incipient displacement of the heart and medistino left and low left pleural effusion, physical examination no alterations to income, so you enter with diagnosis of granulomatous disease study. antigen detection galactomannan reporting positive in two determinations so the diagnosis of invasive pulmonary aspergillosis rethinks meets voriconazole for 21 days, with significant improvement of lung lesions in chest CT scan, graduating with itraconazole therapy is performed to meet for 6 weeks. The early initiation of treatment is a fundamental prognostic factor of invasive aspergillosis, constituting the first line in voriconazole.
first_indexed 2024-03-09T08:59:30Z
format Article
id doaj.art-b4b085ac403c475494ef3fae099fa317
institution Directory Open Access Journal
issn 2244-761X
language English
last_indexed 2024-03-09T08:59:30Z
publishDate 2021-08-01
publisher Universidad Central de Venezuela, Facultad de Medicina.
record_format Article
series Revista Digital de Postgrado
spelling doaj.art-b4b085ac403c475494ef3fae099fa3172023-12-02T12:13:35ZengUniversidad Central de Venezuela, Facultad de Medicina.Revista Digital de Postgrado2244-761X2021-08-01103e32410.37910/RDP.2021.10.3.e324Aspergilosis pulmonar invasiva en paciente pediátricoJenny Planchet0https://orcid.org/0000-0002-6599-8823Rosanny García1Zuneth González2Aura Mendoza3Servicio de Pediatría Médica y Puericultura. Hospital Universitario de Caracas (HUC). Caracas, VenezuelaServicio de Pediatría Médica y Puericultura. Hospital Universitario de Caracas (HUC). Caracas, VenezuelaServicio de Pediatría Médica y Puericultura. Hospital Universitario de Caracas (HUC). Caracas, VenezuelaServicio de Pediatría Médica y Puericultura. Hospital Universitario de Caracas (HUC). Caracas, VenezuelaThe growing emergence of infectious diseases and increasing the number of individuals that have affected their immune competence has become a challenge. Furthermore, considering the genus Aspergillus, as an etiologic agent of infection, which causes significant morbidity and mortality in immunocompromised patients. We present a case of a female preschool 3 years and 8 months with a history of mature teratoma fetiforme, who after 6 months of excision, computed tomography (CT) scan control is performed where central bronchiectasis are evident with tubular opacities and saculares bronchial distribution, located mainly in the upper lobe of left chest, decreased left lung volume with incipient displacement of the heart and medistino left and low left pleural effusion, physical examination no alterations to income, so you enter with diagnosis of granulomatous disease study. antigen detection galactomannan reporting positive in two determinations so the diagnosis of invasive pulmonary aspergillosis rethinks meets voriconazole for 21 days, with significant improvement of lung lesions in chest CT scan, graduating with itraconazole therapy is performed to meet for 6 weeks. The early initiation of treatment is a fundamental prognostic factor of invasive aspergillosis, constituting the first line in voriconazole.http://saber.ucv.ve/ojs/index.php/rev_dp/article/view/22820aspergillosisimmunitypulmonary diseasepediatric
spellingShingle Jenny Planchet
Rosanny García
Zuneth González
Aura Mendoza
Aspergilosis pulmonar invasiva en paciente pediátrico
Revista Digital de Postgrado
aspergillosis
immunity
pulmonary disease
pediatric
title Aspergilosis pulmonar invasiva en paciente pediátrico
title_full Aspergilosis pulmonar invasiva en paciente pediátrico
title_fullStr Aspergilosis pulmonar invasiva en paciente pediátrico
title_full_unstemmed Aspergilosis pulmonar invasiva en paciente pediátrico
title_short Aspergilosis pulmonar invasiva en paciente pediátrico
title_sort aspergilosis pulmonar invasiva en paciente pediatrico
topic aspergillosis
immunity
pulmonary disease
pediatric
url http://saber.ucv.ve/ojs/index.php/rev_dp/article/view/22820
work_keys_str_mv AT jennyplanchet aspergilosispulmonarinvasivaenpacientepediatrico
AT rosannygarcia aspergilosispulmonarinvasivaenpacientepediatrico
AT zunethgonzalez aspergilosispulmonarinvasivaenpacientepediatrico
AT auramendoza aspergilosispulmonarinvasivaenpacientepediatrico